Insights

Innovative Biomaterials Syntellix specializes in bio-absorbable magnesium-based implants, offering a disruptive technology that transforms into bone tissue, reducing long-term risks and the need for additional surgeries. This innovative approach can appeal to healthcare providers seeking advanced, patient-friendly solutions.

Regulatory Success With product approvals in over 70 countries and regions and a breakthrough device designation from the U.S. FDA, Syntellix demonstrates strong regulatory credibility and market readiness, creating opportunities for partnerships and expansion in key international markets.

Clinical Provenance The company’s MAGNEZIX implants have been proven in tens of thousands of surgeries and backed by more than 45 scientific publications, providing compelling evidence for hospitals and surgeons considering innovative implant options.

Market Potential Targeting a potential patient base of over 3.8 billion people globally, Syntellix’s technology has significant growth opportunities, especially in regions emphasizing minimally invasive and cost-effective treatments.

Growth Opportunities Despite current revenue between zero and one million dollars, Syntellix’s unique technology and global regulatory approvals position it for rapid expansion, particularly through strategic partnerships, international marketing, and healthcare provider engagement.

Syntellix AG Tech Stack

Media & News

Syntellix AG's Email Address Formats

Syntellix AG uses at least 1 format(s):
Syntellix AG Email FormatsExamplePercentage
Last@syntellix.comDoe@syntellix.com
50%
Last@syntellix.comDoe@syntellix.com
50%

Frequently Asked Questions

Where is Syntellix AG's headquarters located?

Minus sign iconPlus sign icon
Syntellix AG's main headquarters is located at 2a Aegidientorplatz Hannover, Lower Saxony 30159 Germany. The company has employees across 4 continents, including EuropeAsiaNorth America.

What is Syntellix AG's official website and social media links?

Minus sign iconPlus sign icon
Syntellix AG's official website is syntellix.com and has social profiles on LinkedIn.

What is Syntellix AG's NAICS code?

Minus sign iconPlus sign icon
Syntellix AG's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Syntellix AG have currently?

Minus sign iconPlus sign icon
As of March 2026, Syntellix AG has approximately 16 employees across 4 continents, including EuropeAsiaNorth America. Key team members include Chief Sales Officer: O. M.Head Pharmacist (ra/Qa): P. R.Founder, Ceo & Cdo (chief Disruption Officer): U. C.. Explore Syntellix AG's employee directory with LeadIQ.

What industry does Syntellix AG belong to?

Minus sign iconPlus sign icon
Syntellix AG operates in the Medical Equipment Manufacturing industry.

What is Syntellix AG's email format?

Minus sign iconPlus sign icon
Syntellix AG's email format typically follows the pattern of Last@syntellix.com. Find more Syntellix AG email formats with LeadIQ.

When was Syntellix AG founded?

Minus sign iconPlus sign icon
Syntellix AG was founded in 2008.

Syntellix AG

Medical Equipment ManufacturingLower Saxony, Germany11-50 Employees

Syntellix is a highly innovative med-tech and biomaterials pioneer, specializing in the research, development, manufacturing and sales of bio-absorbable magnesium-based implants. 
Stable as traditional titanium or stainless steel, its MAGNEZIX® implants offer the huge advantage that they turn into bone tissue in due time. Thus, they are avoiding the patients’ burden to live with a foreign material inside the body forever, including possible long-term risks, or of having to suffer a second surgery for implant removal with the associated infection, refracture and anesthesia risks. 
Proven in tens of thousands of surgeries, and evaluated positively by more than 45 scientific publications, its disruptive MAGNEZIX® devices are even described as being “clinically superior” to conventional titanium (or steel). In a nutshell: Half the time, half the cost, half the pain, half the suffering and half the infection risk.
Syntellix has already received product approvals for more than 70 countries and regions with 3.8 billion potential patients. The highly respected U.S. FDA has even granted its MAGNEZIX® CS 3.2 key implant the designation of a “Breakthrough Device”. Syntellix intends to accelerate international growth further, and to give patients, doctors, potential partners and investors the chance to join the Syntellix community and participate in the value creation potential of its globally unique, patent-protected, cutting-edge technology.

Section iconCompany Overview

Headquarters
2a Aegidientorplatz Hannover, Lower Saxony 30159 Germany
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2008
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $1M

    Syntellix AG's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $1M

    Syntellix AG's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.